
Preventing Pregnancy-Related Deaths: 3 Expert Insights for Primary Care From ACOG 2026
Experts discuss maternal mortality trends after COVID-19, missed opportunities in pregnancy-related infection deaths, and practical syphilis screening and management.
In 2024, 649 women died of maternal causes in the US, for a maternal mortality rate of 17.9 deaths per 100 000 live births, according to the latest data from the National Center for Health Statistics (NCHS).1 While that rate is well below the pandemic peak of 32.9 per 100 000 in 2021, stark disparities persist: the rate among Black women (44.8 per 100 000) was more than 3 times that among White women (14.2 per 100 000).1
Most of these deaths are preventable, and many occur after delivery, when patients may be back in the care of their primary care physician (PCP), an urgent care clinic, or an emergency department rather than an obstetrician. To better understand where primary care fits into prevention, Patient Care Online sat down with 3 experts at the 2026 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting, held May 1-3 in Washington, DC, to discuss maternal mortality after the COVID-19 pandemic, pregnancy-related deaths due to infection, and syphilis screening and management.
Maternal mortality after COVID-19
At the meeting, David Goodman, PhD, of the US Centers for Disease Control and Prevention (CDC), presented data from 2 CDC surveillance systems: the Pregnancy Mortality Surveillance System, which tracks pregnancy-related deaths nationally, and data from state maternal mortality review committees (MMRCs), which conduct in-depth reviews of each death.
Pregnancy-related deaths, defined as deaths during pregnancy or within 1 year after its end that are causally related to the pregnancy, rose sharply during the pandemic. “The pregnancy-related mortality ratio just about doubled in 2021 compared to 2019,” Goodman said in an
That persistent elevation may reflect a residual effect of the pandemic itself, apart from COVID-19 infection, Goodman explained, which “might be leading to some of the increases we're seeing in hemorrhage [and] in cardiovascular conditions in the post-pandemic period.”
The recovery has also been uneven. Most racial and ethnic groups have returned to their pre-pandemic risk, “which I should say was never an acceptable level,” Goodman noted. “But among Native and Black people, they've not returned in the post-pandemic period to their pre-pandemic pregnancy-related risks.” Only about half of US Department of Health and Human Services regions have returned to pre-pandemic levels, he added.
4 leading causes, 4 recurring gaps
The leading causes of pregnancy-related death have been consistent across time periods: cardiovascular conditions, infection, and hemorrhage. When MMRC data are included, which allow reviewers to determine whether deaths from suicide or unintentional overdose were pregnancy related, mental health conditions emerge as the leading cause in both the pre-pandemic and pandemic periods.
MMRCs also assess preventability. “It's exciting and encouraging to know that they have found that through specific and feasible changes at the patient, provider, facility, community, [and] systems level, over 80% of these deaths can be prevented,” Goodman said. For each death, committees typically identify 6 to 7 contributing factors and 5 to 6 prevention recommendations.
Across time periods, 4 classes of contributing factors consistently ranked among the top 5: continuity of care, quality of care, knowledge, and access.
For clinicians who want to know where prevention efforts should be focused locally, Goodman pointed to state MMRC reports, which are more widely available than ever. The CDC's ERASE MM web page includes a map that links to each state's review committee and its most recent recommendations.
Check out
Infection: a leading, and largely preventable, cause
Infection accounts for nearly 1 in 10 pregnancy-related deaths in the US. In late-breaking research presented at ACOG 2026, Naima T. Joseph, MD, MPH, a maternal-fetal medicine specialist at Boston Medical Center and assistant professor at Boston University School of Medicine, and colleagues analyzed MMRC data from 29 states on 91 pregnancy-related deaths due to infection between 2017 and 2019.2
Of the 88 deaths with a preventability assessment, 86.4% were deemed preventable.2 “The preventability was due to gaps in recognition on behalf of health care clinicians, as well as by patients, of early warning signs, delays in access to care, delays in access to treatment, as well as a need for broader system-level interventions,” Joseph said in an
Among the study's key findings2:
- Source. The genital tract was the most common source of infection, accounting for 47.9% of deaths with a documented source.
- Pathogen. Group A Streptococcus was the leading pathogen, identified in 34.0% of deaths with a known pathogen.
- Timing. More than one-third of deaths (36.4%) occurred 7 to 42 days postpartum.
- Treatment delays. Only 2 of 17 decedents with documented intervals received antibiotics within 1 hour of symptomatic presentation.
- Contributing factors. The most common were clinical skill and quality of care, delay, knowledge, lack of continuity of care, and lack of access or financial resources.
Missed opportunities outside the hospital
Often, infection simply went unrecognized. “Many times it was just that clinicians hadn't done an exam of those areas to determine that they were infected,” Joseph said. Group A Streptococcus, she added, “can be associated with really rapid clinical deterioration, but has a lot of different clinical presentations, and so was largely under-recognized in this population.”
Two-thirds of deaths (67%) occurred in hospitals, and most patients had prior contact with the health care system, either inpatient or outpatient. Pregnancy physiology often overlaps with sepsis physiology, Joseph explained, which underscores the need for standardized maternal early warning criteria. Notably, about 17% of deaths occurred in nonobstetric settings, such as emergency departments and urgent care clinics.
“It's as important [for] obstetricians and emergency physicians and primary care physicians to recognize maternal physiology and warning signs and to perform a pelvic exam when indicated, especially in someone that is pregnant or recently pregnant,” she said.
The postpartum period is a particularly important window for primary care. Many deaths occurred weeks after delivery, Joseph noted, which “does indicate many of those patients are back with their PCP.” She called for broader PCP education around infection, patient education on where to seek care, and pelvic examination when indicated, “including examining [the] genital tract, the genitourinary tract, [and] incisions, and making sure that you refer patients when appropriate.”
Check out our full
Syphilis: screening before, during, and beyond pregnancy
One infection that primary care can directly prevent from harming newborns is syphilis. Nearly 4000 cases of congenital syphilis were reported in the US in 2024, a 2% increase from 2023 and roughly 700% higher than a decade earlier, according to the CDC.3
“Right now in the United States, we're seeing syphilis increasing among reproductive-age women,” Kathryn Miele, MD, a medical officer with the CDC's Prenatal Exposure Surveillance and Research Team, said in an
CDC guidelines suggest that sexually active people living in areas with high syphilis rates be considered for screening. “I will say that most of us live in a place with a lot of syphilis, and so that includes almost all of the United States population,” Miele said. “When we're doing sexually transmitted infection screening, we should always be including syphilis.”
Screening in pregnancy
In 2024, ACOG updated its guidance to recommend syphilis screening 3 times during every pregnancy: at the initiation of prenatal care, in the early third trimester, and at delivery.4 Miele also encourages screening at the time of pregnancy confirmation for any patient who has not yet established prenatal care, wherever that patient touches the health care system.
“When I get a call from the emergency department at 3 o'clock in the morning about a complication of early pregnancy, after making sure that the patient is safe, I always ask folks to do a syphilis screen,” she said. “We know that a lot of those patients might not come in for traditional prenatal care until later, or maybe even not at all.”
Still, the best prevention starts earlier. “The best way to prevent a congenital syphilis outcome is to diagnose and treat syphilis before pregnancy,” Miele told Patient Care.
Destigmatizing the conversation
To make testing easier to discuss, Miele explains the stakes to patients: syphilis can cause permanent vision and hearing loss, miscarriage, stillbirth, and neonatal death, and it can increase the risk of acquiring and transmitting HIV. “I think a lot of people don't know that syphilis is even around today,” she said. “When we reinforce those messages, I've never had a patient turn down syphilis testing and treatment as needed.”
Titers and partner management
Syphilis results can be confusing, especially low titers. “We're a little bit more comfortable when we see high titer results…but it's those 1:1, 1:2, 1:8s that people get a little confused,” Miele said. Rather than setting aside a confusing result in the electronic health record inbox, she recommends taking a few minutes to work through it, and to “phone a friend” when needed. Clinicians can get free one-on-one consultation through the STD Clinical Consultation Network (stdccn.org), and local health departments, which receive syphilis reports automatically, can help clarify a patient's history.
Partner management is another opportunity. Sex partners of patients with early syphilis (primary, secondary, or early latent) who had sexual contact within the preceding 90 days should be treated presumptively, even if their test results are negative.5 Partners exposed more than 90 days earlier can also be treated presumptively if test results are not immediately available and follow-up is uncertain.5 For nonpregnant partners, Miele noted that this can mean prescribing doxycycline 100 mg twice daily for 14 days. Benzathine penicillin G remains the recommended treatment for syphilis, and it is the only recommended treatment during pregnancy.5
Check out
A note to primary care
Across all 3 interviews, the same message emerged: most pregnancy-related deaths and many adverse outcomes can be prevented, and PCPs are often in the room when it matters, before pregnancy, between prenatal visits, and in the weeks and months after delivery.
That means asking whether a patient is pregnant or recently pregnant, recognizing warning signs of infection, screening for syphilis as part of routine sexually transmitted infection testing, and knowing where to turn for help. “I hope that everyone walks away feeling confident in knowing the resources that are available to them to manage their patients with syphilis, and to feel more comfortable talking with people about syphilis,” Miele said.
For broader prevention priorities, Goodman encouraged clinicians to engage directly with publicly available CDC and state MMRC data. “Go and engage with that information that's available,” he told Patient Care Online. “Take a look at it [and] use it in ways that you think better answer the things that are on your mind.”
References
- Hoyert DL. Maternal mortality rates in the United States, 2024. NCHS Health E-Stats. National Center for Health Statistics. March 4, 2026. doi:10.15620/cdc/174651
- Joseph NT, Trost SL, Hollier LM, et al. Pregnancy-related mortality due to infection: maternal mortality review committees in 29 U.S. states, 2017-2019. Obstet Gynecol. Published online 2026. doi:10.1097/AOG.0000000000006172
- CDC releases 2024 national STI data. Centers for Disease Control and Prevention. September 24, 2025. Accessed November 9, 2026. https://www.cdc.gov/nchhstp/director-letters/release-2024-sti-data.html
- Screening for syphilis in pregnancy. Practice advisory. American College of Obstetricians and Gynecologists. April 2024. [Editor: add URL and access date]
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1
Related to this article








